BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8634929)

  • 1. Intravenous omeprazole prevents rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized controlled study.
    Chua RT; Lin HJ; Wang K; Perng CL; Lo WC; Lee CH; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Feb; 57(2):139-45. PubMed ID: 8634929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can optimal acid suppression prevent rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized comparative study.
    Lin HJ; Lo WC; Perng CL; Wang K; Lee FY
    Hepatogastroenterology; 1997; 44(17):1495-9. PubMed ID: 9356879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of intravenous omeprazole on intragastric pH and outcomes in patients with peptic ulcer bleeding after successful endoscopic therapy--a prospective randomized comparative trial.
    Tseng GY; Lin HJ; Lin HY; Perng CL; Lee FY; Lo WC; Chang FY; Lee SD
    Hepatogastroenterology; 1999; 46(28):2183-8. PubMed ID: 10521964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy.
    Lin HJ; Lo WC; Lee FY; Perng CL; Tseng GY
    Arch Intern Med; 1998 Jan; 158(1):54-8. PubMed ID: 9437379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial.
    Lin HJ; Lo WC; Cheng YC; Perng CL
    Am J Gastroenterol; 2006 Mar; 101(3):500-5. PubMed ID: 16542286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of oral omeprazole and intravenous cimetidine in reducing complications of duodenal peptic ulcer.
    Khoshbaten M; Fattahi E; Naderi N; Khaleghian F; Rezailashkajani M
    BMC Gastroenterol; 2006 Jan; 6():2. PubMed ID: 16403233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor responders to intravenous omeprazole in patients with peptic ulcer bleeding.
    Hsieh YH; Lin HJ; Tseng GY; Perng CL; Wang K; Lo WC; Chang FY; Lee SD
    Hepatogastroenterology; 2004; 51(55):316-9. PubMed ID: 15011893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trial of standard versus high-dose intravenous omeprazole after endoscopic therapy in high-risk patients with acute peptic ulcer bleeding.
    Chan WH; Khin LW; Chung YF; Goh YC; Ong HS; Wong WK
    Br J Surg; 2011 May; 98(5):640-4. PubMed ID: 21305536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study.
    Jensen DM; Pace SC; Soffer E; Comer GM;
    Am J Gastroenterol; 2006 Sep; 101(9):1991-9; quiz 2170. PubMed ID: 16968504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seven-day intravenous low-dose omeprazole infusion reduces peptic ulcer rebleeding for patients with comorbidities.
    Cheng HC; Chang WL; Yeh YC; Chen WY; Tsai YC; Sheu BS
    Gastrointest Endosc; 2009 Sep; 70(3):433-9. PubMed ID: 19500787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial.
    Zargar SA; Javid G; Khan BA; Yattoo GN; Shah AH; Gulzar GM; Sodhi JS; Mujeeb SA; Khan MA; Shah NA; Shafi HM
    J Gastroenterol Hepatol; 2006 Apr; 21(4):716-21. PubMed ID: 16677158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regular-dose versus high-dose omeprazole in peptic ulcer bleeding: a prospective randomized double-blind study.
    Udd M; Miettinen P; Palmu A; Heikkinen M; Janatuinen E; Pasanen P; Tarvainen R; Kairaluoma MV; Lohman M; Mustonen H; Julkunen R
    Scand J Gastroenterol; 2001 Dec; 36(12):1332-8. PubMed ID: 11761026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.
    Lau JY; Sung JJ; Lee KK; Yung MY; Wong SK; Wu JC; Chan FK; Ng EK; You JH; Lee CW; Chan AC; Chung SC
    N Engl J Med; 2000 Aug; 343(5):310-6. PubMed ID: 10922420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous infusion of high-dose omeprazole is more effective than standard-dose omeprazole in patients with high-risk peptic ulcer bleeding: a retrospective study.
    Simon-Rudler M; Massard J; Bernard-Chabert B; DI Martino V; Ratziu V; Poynard T; Thabut D
    Aliment Pharmacol Ther; 2007 Apr; 25(8):949-54. PubMed ID: 17402999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of rebleeding of peptic ulcer bleeding in patients with comorbid illness receiving omeprazole infusion.
    Cheng HC; Chuang SA; Kao YH; Kao AW; Chuang CH; Sheu BS
    Hepatogastroenterology; 2003; 50(54):2270-3. PubMed ID: 14696515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orally administered omeprazole versus injection therapy in the prevention of rebleeding from peptic ulcer with visible vessel. A multicenter randomized study.
    Bour B; Pariente EA; Hamelin B; Garcia E
    Gastroenterol Clin Biol; 1993; 17(5):329-33. PubMed ID: 8349066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will Helicobacter pylori affect short-term rebleeding rate in peptic ulcer bleeding patients after successful endoscopic therapy?
    Lin HJ; Tseng GY; Hsieh YH; Perng CL; Lee FY; Chang FY; Lee SD
    Am J Gastroenterol; 1999 Nov; 94(11):3184-8. PubMed ID: 10566712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-bleeding visible vessel treatment: perendoscopic injection therapy versus omeprazole infusion.
    Grosso C; Rossi A; Gambitta P; Bini M; Zanasi G; Pirone Z; Arcidiacono R
    Scand J Gastroenterol; 1995 Sep; 30(9):872-5. PubMed ID: 8578185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omeprazole versus ranitidine as adjunct therapy to endoscopic injection in actively bleeding ulcers: a prospective and randomized study.
    Villanueva C; Balanzó J; Torras X; Sáinz S; Soriano G; González D; Vilardell F
    Endoscopy; 1995 May; 27(4):308-12. PubMed ID: 7555936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravenous omeprazole versus ranitidine in the treatment of hemorrhagic duodenal ulcer: a prospective randomized study].
    Cardi M; Muttillo IA; Amadori L; Barillari P; Sammartino P; Arnone F; Signorelli C; Bolognese A
    Ann Chir; 1997; 51(2):136-9. PubMed ID: 9297869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.